产品中心
  Wechat

Wechat

  Contact Us

Address:

5th floor, Building 9, No.8 Shengmingyuan Road, Life Science Park, Zhongguancun, Changping District, Beijing, China

Email:

postmaster@sinotau.com

Tel:

+86-10-8492479489934358

Fax:

+86-10-84920734

Who We Are


Sinotau is a modern vertically integrated pharmaceutical group with focus on both generic and patented therapies as well as diagnostic agents. 

Sinotau Pharmaceuticals Group was founded in 2005. Today the Group is formed by 4 constituent subsidiaries: Hainan Sinotau, Sinotau Medical, Guangdong Shangruihe and Sichuan Shanghe. Sinotau has successfully transformed from a CRO company into a modern pharmaceutical group with a diversified approach to the pharma business, combining R&D, manufacturing, marketing and distribution in the Chinese market. 

Hainan Sinotau and Sinotau Medical are the backbone of the Group. Hainan Sinotau is the marketing and distribution arm of the Group, and also serves as a national agent for both domestic and international partners. Sinotau Medical is a biotech platform oriented in R&D for Alzheimer disease, tumors and angiocarpy, among others therapies.    

The Group has strong Regulatory and R&D teams with a profound knowledge of the registration pathways pertaining the filling of ANDAs for local and foreign formulations as well as NDAs for patented products. 


Our Future


  • Ongoing transformation of the company structure. From a traditional Chinese pharma company to a modern leading player in the Chinese market with integrated domestic and international resources for R&D, marketing and distribution. Aims at accurate diagnosis and treatment, and focuses on innovative pharmaceuticals.
  • Expansion of patented portfolio to include broad array of conditions and clinical needs in China. 
  • Expansion of generic pipeline into allied products that complement and augment patented portfolio. 
  • Import and registration of novel technologies that provide more effective therapies to physicians across China.